Friday, May 20, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Newly discovered immune cell “soldier” could be a good target for immunotherapy

by Medical Finance
in News
PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies
9
SHARES
99
VIEWS
Share on FacebookShare on Twitter

Despite the success of immunotherapy in helping many people with cancer, the majority of patients still do not respond to these treatments. There is need for continued research.

On April 20, 2022, researchers at the Sloan Kettering Institute reported in the journal Nature that a recently discovered new immune cell “soldier” could be a good target for immunotherapy, raising hopes that it might help narrow the gap between people who respond and those who do not.

The new cells, which the scientists have dubbed killer innate-like T cells, differ in notable ways from the conventional target of many immunotherapies -; the cytotoxic (aka “killer”) T cells. For one, they don’t get exhausted from extended activity like cytotoxic T cells do. And two, they can penetrate more deeply into tissues where cancer is hiding. These unique attributes make them attractive as a target for immunotherapy.

We think these killer innate-like T cells could be targeted or genetically engineered for cancer therapy. They may be better at reaching and killing solid tumors than conventional T cells.”


Ming Li, immunologist in SKI and lead author of the new study

Pinning down what makes the cells distinct

Dr. Li’s team first reported the existence of this unusual cell population in 2016. At that time, it was clear to his team that these cells had the power to kill cancer cells, but they knew little about where the cells come from or how they work.

For this new study, Dr. Li and colleagues used a variety of techniques, including single-cell analysis and CRISPR genome editing, to further characterize the cells.

They made several startling discoveries. For one, killer innate-like T cells don’t make the immune checkpoint molecule PD-1 and, as a consequence, do not appear to become exhausted the way typical killer T cells do. This is an attractive feature in a potential immune cell therapy.

The cells also appear to recognize different markers, or antigens, on cancer cells. Whereas conventional killer T cells recognize specific mutated antigens (called neoantigens), the killer innate-like T cells recognize a much broader range of non-mutated (that is, normal) antigens.

Killer innate-like T cells also don’t depend on antigen-presenting cells, such as dendritic cells, to alert them to the presence of dangerous-looking antigens. In this way, they behave more like innate immune cells that are always primed and ready for attack.

Lastly, unlike conventional T cells, they don’t recirculate throughout the blood and lymph fluid, making stops in lymph nodes. Rather, they appear to home directly to tissues throughout the body, where they seek out danger.

All of these make them of particular interest as a target of immunotherapy, Dr. Li says.

A unique fate that avoids autoimmunity and suppresses cancer

The fact that killer innate-like T cells recognize unmutated antigens in the body raises the question of why these cells don’t cause autoimmunity -; when the immune system attacks normal parts of the body. Dr. Li says it’s because they get reprogrammed during their development.

Typically, developing T cells that react strongly to normal antigens are proactively killed off by the body to prevent autoimmune reactions. But the killer innate-like T cells escape that fate. Instead, their T cell receptor machinery gets tamped down, rendering these cells harmless to normal cells in the body.

At the same time, they become much more sensitive to a molecule called IL-15 that is produced by many cancer cells and is recognized as an “alarmin” -; a danger signal that prods the immune system into action. The team found that if they delete IL-15 from cancer cells, then the protection provided by the killer innate-like T cells was eliminated and tumor growth increased.

Because IL-15 isn’t highly produced in healthy tissues, the killer innate-like T cells would not be spurred into action there, and therefore would not cause unwanted damage.

Dr. Li’s team did most of their experiments in mice, but they confirmed that these killer innate-like T cells are present in human tumors, including colon cancer tumors from patients at MSK. They are excited about the possibility of working with doctors at MSK to translate these findings from the lab to the clinic, where they might ultimately help patients.

Source:

Memorial Sloan Kettering Cancer Center

Journal reference:

Chou, C., et al. (2022) Programme of self-reactive innate-like T cell-mediated cancer immunity. Nature. doi.org/10.1038/s41586-022-04632-1.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Bacterial biofilms use a developmental patterning mechanism seen in plants and animals

Fecal microbiota transplant can reverse hallmarks of aging in mice

by Medical Finance
May 20, 2022
0

In the search for eternal youth, poo transplants may seem like an unlikely way to reverse the aging process. However,...

Researchers unravel how parent’s gene impact the behavior of children

Researchers unravel how parent’s gene impact the behavior of children

by Medical Finance
May 20, 2022
0

Parenting is not the only way moms and dads impact the behavior of their offspring. Genes matter, too. And although...

Low profile microplates optimise space utilisation

Low profile microplates optimise space utilisation

by Medical Finance
May 20, 2022
0

Porvair Sciences low profile microplates offer the highly efficient use of stacking space that is essential to achieving efficient automation...

Scientists shed light on placenta’s role in transferring vitamin D to fetus during pregnancy

Scientists shed light on placenta’s role in transferring vitamin D to fetus during pregnancy

by Medical Finance
May 20, 2022
0

Scientists have shed new light on the role of the placenta in managing the relationships between maternal vitamin D and...

New evidence supports the link between growth-induced respiratory stress and fish reproduction

LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

by Medical Finance
May 20, 2022
0

LMU scientists have investigated how most people's immune defenses are able to curb the coronavirus so effectively that pneumonia does...

Genome editing in vascular endothelial cells made possible with a powerful new delivery system

Genome editing in vascular endothelial cells made possible with a powerful new delivery system

by Medical Finance
May 20, 2022
0

Northwestern Medicine scientists developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, to endothelial cells, which line blood...

Next Post
Study: SARS-CoV-2 Infections in Professional Orchestra and Choir Musicians – A Prospective Cohort Study. Image Credit: Skreidzeleu/Shutterstock

Incidence of SARS-CoV-2 infections in orchestra and choir musicians

Study: NRP1 and furin as putative mediators of SARS-CoV-2 entry into human brain cells. Image Credit: Kateryna Kon/Shutterstock

Researchers discover mechanism behind SARS-CoV-2 entry into the brain

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Respiratory 620x480
    Respiratory virus particles likely travel greater distance than previously thought
  • Study: Rapid screening assays of N501Y and E484K SARS-CoV-2 variants and identification of an emerging N501T variant in France. Image Credit: Salov Evgeniy / Shutterstock.com
    Novel screening method detects new N501T SARS-CoV-2 variant
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply